Robuta

https://biosimilarscanada.ca/ Home - Biosimilars Canada Apr 20, 2026 - Biosimilars Canada Code of ConductView the Biosimilars Canada Code of Conduct You can have confidence in your biosimilar medicines Learn moreSwitching to... biosimilarscanada https://biosimilarsresources.org/ Home | Biosimilars | Patient Resource Center | Biosimilar Medicines Sep 13, 2024 - Biosimilar medicines give 1.2 million patients in the United States access to life-changing results. Learn more about these medicines. patient resource centerbiosimilarsmedicines https://biosimilarscouncil.org/ Home | Biosimilars Council | Leading Resource on Biosimilars Apr 2, 2026 - The Biosimilars Council, a division of the Association for Accessible Medicines, works to ensure a positive future for biosimilar medicines. biosimilars councilleadingresource https://www.biocon.com/businesses/biosimilars/our-work-in-biosimilars/ Our work in Biosimilars - Biocon - Global Biopharmaceutical company Nov 4, 2025 - Biocon Biologics has one of the largest global biosimilars portfolios spanning recombinant human Insulin (rh-Insulin), insulin analogs... our workbiosimilarsbioconglobalbiopharmaceutical https://www.canadianbiosimilarsforum.ca/ Canadian Biosimilars Forum The Canadian Biosimilars Forum is an alliance of companies who represent the breadth of the biosimilars industry and who are collectively working to increase... canadianbiosimilarsforum https://www.biosimilarshandbook.org/medical-professional-learning-track/ Medical Professional Learning Track - Biosimilars Handbook medical professionallearningtrackbiosimilarshandbook https://ciplabiosimilars.co.za/ Cipla Biosimilars Jun 12, 2025 - Cipla has a legacy of value based generics. Cipla is also focusing on biosimilars and educating on the science behind these medicines. ciplabiosimilars https://globalbiosimilarsweek.org/2025/ Global Biosimilars Week 2025 Sep 29, 2025 - IGBA will be hosting the 6th annual Global Biosimilars Week from 3-7 November 2025. This social media campaign aims to raise awareness of the powerful impact... globalbiosimilarsweek https://biosimilairescanada.ca/ Accueil - Biosimilars Canada Jul 21, 2026 - Code de conduite de Biosimilaires CanadaConsultez le Code de Conduite de Biosimilaires Canada Vous pouvez avoir confiance dans les médicaments biosimilaires... accueilbiosimilarscanada https://www.hhs.gov/guidance/document/development-therapeutic-protein-biosimilars-comparative-analytical-assessment-and-other Development of Therapeutic Protein Biosimilars: Comparative Analytical Assessment and Other... therapeutic proteindevelopmentbiosimilarscomparativeanalytical https://clarivate.com/life-sciences-healthcare/report/biosbi0010-2016-biopharma-biosimilars-emerging-biosimilars-global-2016/ Biosimilars | Emerging Biosimilars | Global | 2016 | Clarivate Abstract Introduction: The Emerging Biosimilars Overview offers extensive coverage of the global biosimilar development landscape. We track over 350 currently... biosimilarsemergingglobalclarivate https://www.researchandmarkets.com/reports/5359104/biosimilars-market-industry-trends-and-global Biosimilars Market Industry Trends and Global Forecasts to 2035 - Distribution by Drug Class,... Biosimilars Market Industry Trends and Global Forecasts to 2035 - Distribution by Drug Class, Therapeutic Area, Type of Manufacturer, Distribution Channel,... https://www.biosimilarsip.com/ Biosimilars Law Bulletin | Rothwell Figg | Biologics and Biosimilars Practice Authored and edited by Rothwell Figg attorneys, Biosimilars Law Bulletin provides updates and analysis about regulatory issues, legal decisions and other news... law bulletinbiosimilarsrothwellfiggbiologics https://www.researchandmarkets.com/reports/5395376/biosimilars-market-2025-2029 Biosimilars Market 2025-2029 - Research and Markets This report features 19 companies, including Samsung Biologics Co. Ltd., Biocon Ltd., Pfizer Inc., Gedeon Richter Plc, Sanofi SA, Teva Pharmaceutical... biosimilars marketresearchmarkets https://www.govinfo.gov/app/details/BILLS-119s1414is S. 1414 (IS) - Expedited Access to Biosimilars Act - BILLS-119s1414is | Content Details | GovInfo https://www.prnewswire.com/news-releases/safety-for-biosimilars-strategic-pharmacovigilance-solutions-upcoming-webinar-hosted-by-xtalks-302573364.html Safety for Biosimilars: Strategic Pharmacovigilance Solutions, Upcoming Webinar Hosted by Xtalks In this free webinar, gain insight into the evolving global regulatory landscape for biosimilar approval, labelling and pharmacovigilance requirements.... upcoming webinarhosted bysafetybiosimilarsstrategic https://clarivate.com/life-sciences-healthcare/report/biosbi0008-2017-biopharma-biosimilars-current-treatment-nephrology-us-eu-2017/ Biosimilars | Current Treatment | Nephrology | US/EU | 2017 | Clarivate Although ESA biosimilars entered the European market a decade ago, their uptake varies from country to country, as well as by drug and manufacturer. While... biosimilarscurrenttreatmentnephrologyus https://www.researchandmarkets.com/reports/4636693/global-biosimilars-partnering-terms-and Global Biosimilars Partnering Terms and Agreements 2010 to 2023 This report features 186 companies, including Gedeon Richter, CEA, Manguinhos/Fiocruz, Natco Pharmaceuticals, Bridge Capital, PT Etana Biotechnologies, Pfenex terms and agreementsglobalbiosimilarspartnering https://app-stadare-prod-uks-frontend.azurewebsites.net/biosimilars-stada/blog/posts/2020/august/can-biosimilars-drive-value-beyond-just-price Can biosimilars drive value beyond just price? | Biosimilars biosimilarsdrivevaluebeyondprice https://www.globenewswire.com/fr/news-release/2026/04/17/3276022/28124/en/middle-east-and-africa-biosimilars-market-trends-report-2026-2035-profiles-of-abbvie-amgen-biocon-celltrion-dr-reddy-s-pfizer-roche-samsung-sandoz-teva-viatris.html Middle East and Africa Biosimilars Market Trends Report The Middle East and Africa biosimilars market is poised for strong growth due to patent expiries, increased chronic disease prevalence, and supportive... middle east and africabiosimilars markettrendsreport https://www.fda.gov/news-events/congressional-testimony/biosimilars-implementation Biosimilars Implementation | FDA Testimony of Janet Woodcock, M.D., before the House Committee on Energy and Commerce, February 4, 2016 biosimilarsimplementationfda https://www.tevabiosimilars.com/ Teva Biosimilars | A Global Portfolio of Biosimilars Teva Biosimilars: Learn about our global portfolio of biosimilars a globaltevabiosimilarsportfolio https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0292231 Safety outcomes when switching between biosimilars and reference biologics: A systematic review and... Biosimilars are increasingly available for the treatment of many serious disorders, however some concerns persist about switching a patient to a biosimilar... https://hku.hk/press/press-releases/detail/27575.html HKUMed finds biosimilars offer improved outcome and lower cost for rheumatoid arthritis treatment -... HKUMed study finds biosimilars provide better outcome and lower cost for rheumatoid arthritis treatment. Research team members include (from right) Professor... https://pmc.ncbi.nlm.nih.gov/articles/PMC8039027/ Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications... Trastuzumab is a biologic therapy indicated for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer and metastatic gastric... intravenoussubcutaneousformulationstrastuzumabbiosimilars https://kkumar.exblog.jp/245254933/ Exploring Insulin Glargine Biosimilars: Key Insights for 2024 : Stay Ahead in Pharma with... The diabetes treatment landscape has witnessed remarkable evolution with the ... https://biosimilarscongress.com/ Biosimilars & Biologics World Congress Europe - Biosimilar & Biologics World Congress Europe world congressbiosimilarsbiologicseurope https://health.economictimes.indiatimes.com/news/pharma/cipla-kemwell-form-jv-for-developing-commercialising-biosimilars/85644377 Cipla, Kemwell form JV for developing, commercialising biosimilars, ETHealthworld Pharma firm Cipla and Kemwell Biopharma on Wednesday announced the execution of a joint venture agreement to develop, manufacture and commercialise biosimilars... ciplakemwellformjvdeveloping https://bioconbiologics.ca/ Biosimilars in Canada | Biocon Biologics Canada Official Site Dec 11, 2025 - Discover how Biocon Biologics supports Canada’s biosimilar ecosystem with high-quality, affordable therapies in oncology, diabetes, immunology, and... in canadabiocon biologicsbiosimilarsofficialsite https://pharmacy.temple.edu/academics/regulatory-affairs-quality-assurance-ms-programs-non-thesis-certificates/about/certificate-programs-raqa/pre-masters-certificates-raqa/biologics-biosimilars-regulatory-aspectspre-masters-raqa/biologics-biosimilars-regulatory-aspectspre-masters Biologics and Biosimilars: Regulatory Aspects(Pre-Master's) (RAQA) | Regulatory Affairs & Quality... biologics and biosimilarsregulatoryaspects https://petrieflom.law.harvard.edu/2020/01/31/the-rise-of-biosimilars-success-of-the-bpcia/ The Rise of Biosimilars: Success of the BPCIA? (Part I) - Petrie-Flom Center Jan 9, 2026 - By Jonathan Darrow This is Part I in a series exploring the history, challenges, and opportunities in the regulation of biosimilars, or biologic medical... the risebiosimilarssuccess https://www.bcg.com/publications/2024/rising-tide-lifts-us-biosimilars-market Rising Tide Lifts US Biosimilars Market | BCG May 22, 2025 - The US biosimilars market is experiencing strong growth as regulations evolve and physician confidence in these products grows. But market patterns are... rising tidebiosimilars marketliftsusbcg https://clarivate.com/life-sciences-healthcare/report/biosbi0017-2026-biopharma-biosimilars-forecast-oncology/ Biosimilars - Forecast - Oncology | Clarivate In 2024, sales of branded MAb biologics in oncology exceeded $48 billion in the major pharmaceutical markets (United States, EU5, and Japan), and sales of... biosimilarsforecastoncologyclarivate https://events.marketsandmarkets.com/marketsandmarkets-biosimilars-digital-conference/ MarketsandMarkets Biosimilars Digital Conference marketsandmarketsbiosimilarsdigitalconference https://stadaspecialtybiosimilars.co.uk/ STADA Specialty & Biosimilars UK STADA: Caring for people’s health as a trusted partner STADA is a leading European company, established by physicians and pharmacists. Manufacturing and... stadaspecialtybiosimilarsuk https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=39297 LCD - Off-label Use of Rituximab and Rituximab Biosimilars (L39297) Use this page to view details for the Local Coverage Determination for Off-label Use of Rituximab and Rituximab Biosimilars. off labellcduserituximabbiosimilars https://www.globenewswire.com/fr/news-release/2026/02/16/3238646/28124/en/india-biosimilars-market-trends-and-forecasts-2026-2035-biologics-patent-expirations-strategic-partnerships-and-government-incentives-driving-opportunities.html India Biosimilars Market Trends and Forecasts 2026-2035: The India biosimilars market growth is driven by biologics patent expirations, strategic partnerships, and government incentives, offering opportunities in... biosimilars marketindiatrendsforecasts https://www.researchandmarkets.com/reports/6187436/bevacizumab-biosimilars-market-outlook-market Bevacizumab Biosimilars Market Outlook 2025-2034: Market Share, and Growth Analysis The Bevacizumab Biosimilars Market, valued at USD 2.1B in 2025, is projected to reach USD 4.3B by 2034, growing at a 8.2% CAGR. biosimilars marketbevacizumaboutlooksharegrowth https://www.globenewswire.com/fr/news-release/2026/02/04/3232362/28124/en/oncology-biosimilars-research-and-global-forecast-report-2025-2030-targeted-therapies-emerging-market-expansion-and-novel-biosimilar-formulations-drive-growth.html Oncology Biosimilars Research and Global Forecast Report Key market opportunities in oncology biosimilars include leveraging AI for streamlined clinical trials and precision medicine, enhancing efficiency and... global forecastoncologybiosimilarsresearchreport https://www.business-standard.com/companies/interviews/will-launch-3-biosimilars-globally-in-2-3-years-biocon-biologics-ceo-124110501250_1.html Will launch 3 biosimilars globally in 2-3 years: Biocon Biologics CEO & MD | Interviews - Business... https://rss.globenewswire.com/en/news-release/2024/06/20/2901458/28124/en/Biosimilars-Training-Course-Prepare-for-Growth-as-Some-of-the-World-s-Best-known-Biologics-Face-Patent-Expiration-in-the-Coming-Years-ONLINE-EVENT.html Biosimilars Training Course: Prepare for Growth as Some of Dublin, June 20, 2024 (GLOBE NEWSWIRE) -- The training courseprepare forbiosimilarsgrowth https://www.techtarget.com/pharmalifesciences/news/366607714/New-Study-Finds-Significant-Cost-Savings-from-Biosimilars-Use New Study Finds Significant Cost Savings from Biosimilars Use | TechTarget A recent study uncovered that biosimilars could save companies nearly $1.53 million. significant cost savingsnew studyfindsbiosimilarsuse https://economictimes.indiatimes.com/topic/biosimilars-and-peptides biosimilars and peptides: Latest News & Videos, Photos about biosimilars and peptides | The... biosimilars and peptides Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. biosimilars and peptides Blogs, Comments and... latest news videosbiosimilarspeptidesphotos https://www.temple.edu/academics/degree-programs/biologics-biosimilars-manufacturing-certificate-graduate-ph-bbmn-grad/post-masters-certificate PHR Biologics and Biosimilars Manufacturing Post-master's Certificate | Temple University biologics and biosimilarsphrmanufacturing https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0262537 Interchangeability of biosimilars: A study of expert views and visions regarding the science and... Healthcare systems have reached a critical point regarding the question of whether biosimilar substitution should become common practice. To move the... a studyexpert views https://health.economictimes.indiatimes.com/news/pharma/india-tops-the-chart-for-approved-biosimilars-and-clinical-trials-surpassing-usa-and-europe-10th-annual-pharma-ipr-india-conference/86482496 India tops the chart for approved biosimilars and clinical trials surpassing USA and Europe: 10th... 10th Annual Pharma IPR India Conference: The event witnessed innovative exchange of thoughts with an aim to create an efficient IP framework globally to... https://www.fda.gov/drugs/biosimilars/biosimilars-drop-articles Biosimilars Drop-In Articles | FDA Biosimilars Drop-In Content drop inbiosimilarsarticlesfda https://health.economictimes.indiatimes.com/news/pharma/supply-chain-logistics/biocon-biologics-completes-integration-of-acquired-biosimilars-business-in-70-countries-in-emerging-markets/101520104 Biocon Biologics completes integration of acquired biosimilars business in 70+ countries in... Following the deal closure in November 2022, this marks the first wave of countries where Viatris' operations have fully transitioned to Biocon Biologics. A... biocon biologicscompletesintegration https://clarivate.com/life-sciences-healthcare/report/biosbi0005-2018-biopharma-biosimilars-corporate-strategies-global-2018/ Biosimilars | Corporate Strategies | Global | 2018 | Clarivate The development and commercialization of biosimilars require a significant investment in capital, resources, and time. Biosimilar developers must ensure that... corporate strategiesbiosimilarsglobalclarivate https://www.brookings.edu/events/biosimilars-in-the-united-states-implementation-challenges-and-lessons-learned-from-the-european-union/ Biosimilars in the United States: Implementation Challenges and Lessons Learned from the European... Jul 29, 2016 - The Patient Protection and Affordable Care Act established a legal framework for an abbreviated approval pathway for off-brand versions of biotech drugs, known... in the united statesimplementation challenges https://www.biosimilars-im-dialog.de/ Biosimilars im Dialog Schwangerschaft, Entbindung, Wochenbett biosimilarsdialog https://www.pfizer.com/products/how-drugs-are-made/biologics-and-biosimilars Biologics & Biosimilars | Pfizer biologicsbiosimilarspfizer https://biosim.care/ Biosimilars Care Navigator for Patients Navigate through this Web App to get essential information on the expanding landscape of biosimilars. In addition, the App provides useful resources for... care navigatorbiosimilarspatients https://www.eui.eu/news-hub?id=more-than-copies-velizar-kirilov-on-biosimilars-and-pharmaceutical-innovation More than copies: Velizar Kirilov on biosimilars and pharmaceutical innovation • European... In this MyEUIResearch story, Velizar Kirilov explains why biosimilars can be more than cheaper versions of existing medicines, and what competition law has to more than https://pharma.economictimes.indiatimes.com/tag/wockhardt+biosimilars Wockhardt biosimilars - Latest wockhardt biosimilars , Information & Updates - Pharma -ETPharma ETPharma.com brings latest wockhardt biosimilars news, views and updates from all top sources for the Indian Pharma industry. latest informationwockhardtbiosimilarsupdatespharma https://www.researchandmarkets.com/reports/5774430/united-states-biosimilars-business-investment United States Biosimilars Business and Investment Opportunities Databook - Q2 2023 Update The U.S. Biosimilars Market, valued at USD 3.92B in 2023, is projected to reach USD 11.43B by 2027, growing at a 23.8% CAGR. business and investmentunited statesbiosimilars https://www.aad.org/public/diseases/a-z/biosimilars-patient-questions Biosimilars: 14 questions patients ask their dermatologist Find out what a biosimilar is and get answers to questions that patients frequently ask about this medication. biosimilarsquestionspatientsaskdermatologist https://app-stadare-prod-uks-frontend.azurewebsites.net/biosimilars-stada Bio Similars EN | Biosimilars Here you can learn everything you need to know about biosimilar medicines, how and why they are made, and how they can help people with serious or... bioen https://biosimilarsroadmap.com/ Biosimilars biosimilars https://www.biosimilarsgeneration.ca/ Welcome to the Biosimilars Generation | Biosimilarsgeneration The Biosimilars Generation is the source of information explaining biosimilar medicines in Canada to patients and healthcare providers alike. Learn more. welcome to thebiosimilarsgeneration https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=58582&ver=17 Article - Billing and Coding: Off-label Use of Rituximab and Rituximab Biosimilars (A58582) Use this page to view details for the Local Coverage Article for Billing and Coding: Off-label Use of Rituximab and Rituximab Biosimilars. billing and codingoff labelarticle https://www.fda.gov/regulatory-information/food-and-drug-administration-safety-and-innovation-act-fdasia/fact-sheet-new-biosimilars-user-fees-will-enhance-americans-access-alternatives-biologic-drugs Fact Sheet: New "Biosimilars" User Fees Will Enhance Americans' Access to Alternatives to Biologic... Fact sheet on provisions for user fees for review of biosimilar biologic drugs in the FDA Safety and Innovation Act https://pharma.economictimes.indiatimes.com/tag/guidelines+for+biosimilars Guidelines for biosimilars - Latest guidelines for biosimilars , Information & Updates - Pharma... ETPharma.com brings latest guidelines for biosimilars news, views and updates from all top sources for the Indian Pharma industry. latest informationguidelinesbiosimilarsupdatespharma https://pharma.economictimes.indiatimes.com/tag/fda+approved+biosimilars Fda approved biosimilars - Latest fda approved biosimilars , Information & Updates - Pharma... ETPharma.com brings latest fda approved biosimilars news, views and updates from all top sources for the Indian Pharma industry. fda approvedlatest informationbiosimilarsupdatespharma https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=52370&ver=113&= Article - Billing and Coding: Bevacizumab and biosimilars (A52370) Use this page to view details for the Local Coverage Article for Billing and Coding: Bevacizumab and biosimilars. billing and codingarticlebevacizumabbiosimilars https://www.goodwinlaw.com/en/news-and-events/news/2026/01/announcements-otherindustries-goodwin-releases-2025-26-update-to-annual Goodwin Releases 2025-26 Update to Annual Biosimilars Guide | News & Events | Goodwin goodwinreleasesupdate https://pr.euractiv.com/pr/europabio-publishes-new-report-biological-medicines-special-focus-biosimilars-91615 EuropaBio publishes a new report on biological medicines with a special focus on biosimilars |... To contribute to an informed debate, EuropaBio is launching a new brochure acknowledging the complexity of biotechnology-derived medicines[1] and the emergence... a new report https://www.techtarget.com/pharmalifesciences/feature/Understanding-Differences-between-Generic-Brand-Name-Biosimilars Understanding Differences between Generic, Brand Name, Biosimilars | TechTarget Knowledge of and understanding the differences between generics, brand names, and biosimilars is essential for patients, payers, and providers to make informed... differences betweengeneric brandunderstandingnamebiosimilars https://online.fliphtml5.com/zuhtl/eaxv/ Post-Market Policy Counsel for Biosimilars: To Taiwan Authoritative Agencies Post-Market Policy Counsel for Biosimilars: To Taiwan Authoritative Agencies post marketpolicycounselbiosimilarstaiwan https://www.researchandmarkets.com/reports/5774435/china-biosimilars-business-investment China Biosimilars Business and Investment Opportunities Databook - Q2 2023 Update The Chinese Biosimilars Market, valued at USD 0.88B in 2023, is projected to reach USD 2.22B by 2027, growing at a 20.2% CAGR. business and investmentchinabiosimilarsopportunitiesdatabook https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-first-interchangeable-biosimilars-prolia-and-xgeva-treat-certain-types-osteoporosis-and FDA approves first interchangeable biosimilars to Prolia and Xgeva to treat certain types of... FDA approves first interchangeable biosimilars to Prolia and Xgeva to treat certain types of osteoporosis and prevent bone events in cancer https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=52370&ver=119&= Article - Billing and Coding: Bevacizumab and biosimilars (A52370) Use this page to view details for the Local Coverage Article for Billing and Coding: Bevacizumab and biosimilars. billing and codingarticlebevacizumabbiosimilars https://www.digitaljournal.com/topic/biosimilars biosimilars Archives - Digital Journal The journal of record for the decisions that define how Canadian organizations lead in an innovation economy. Online since 1998. biosimilarsarchivesdigitaljournal https://biosimilars.fresenius-kabi.com/ Fresenius Kabi Biosimilars Explore our 6 FDA-approved biosimilar products in rheumatology, oncology, endocrinology, gastroenterology and dermatology. Also, view our biosimilars pipeline... fresenius kabibiosimilars https://oig.hhs.gov/reports/work-plan/browse-work-plan-projects/effects-of-including-noncovered-versions-of-stelara-biosimilars-in-part-b-payment-amount-calculations/ Effects of Including Noncovered Versions of Stelara Biosimilars in Part B Payment Amount... https://clarivate.com/life-sciences-healthcare/report/biosbi0010-2026-biopharma-biosimilars-emerging-biosimilars-emerging-biosimilars-landscape/ Biosimilars - Emerging Biosimilars - Emerging Biosimilars Landscape | Clarivate The Emerging Biosimilars Landscape offers extensive coverage of the global biosimilars development landscape. We track over 823 currently available and novel... biosimilarsemerginglandscapeclarivate https://probiosimilars.de/ AG Pro Biosimilars Jun 29, 2026 - Die AG Pro Biosimilars ist die Interessenvertretung der Biosimilar-Hersteller in Deutschland und vertritt deren Interessen gegenüber Politik und Öffentlichkeit. ag probiosimilars https://health.economictimes.indiatimes.com/tag/biosimilars Biosimilars - Latest biosimilars , Information & Updates - Health -ET HealthWorld ETHealthworld.com brings latest biosimilars news, views and updates from all top sources for the Indian Health industry. latest informationbiosimilarsupdateshealthet